BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 17079857)

  • 1. [Fibroblast growth factor receptor and achondroplasia].
    Tanaka H
    Clin Calcium; 2006 Nov; 16(11):1888-93. PubMed ID: 17079857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cytokines in bone diseases. FGF receptor signaling and achondroplasia/hypochondroplasia].
    Tanaka H
    Clin Calcium; 2010 Oct; 20(10):1490-6. PubMed ID: 20890030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTHrP rescues ATDC5 cells from apoptosis induced by FGF receptor 3 mutation.
    Yamanaka Y; Tanaka H; Koike M; Nishimura R; Seino Y
    J Bone Miner Res; 2003 Aug; 18(8):1395-403. PubMed ID: 12929929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A common FGFR3 gene mutation is present in achondroplasia but not in hypochondroplasia.
    Stoilov I; Kilpatrick MW; Tsipouras P
    Am J Med Genet; 1995 Jan; 55(1):127-33. PubMed ID: 7702086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid hormone receptor type 1/Indian hedgehog expression is preserved in the growth plate of human fetuses affected with fibroblast growth factor receptor type 3 activating mutations.
    Cormier S; Delezoide AL; Benoist-Lasselin C; Legeai-Mallet L; Bonaventure J; Silve C
    Am J Pathol; 2002 Oct; 161(4):1325-35. PubMed ID: 12368206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis.
    Krejci P; Masri B; Fontaine V; Mekikian PB; Weis M; Prats H; Wilcox WR
    J Cell Sci; 2005 Nov; 118(Pt 21):5089-100. PubMed ID: 16234329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Ser(365)-->Cys mutation of fibroblast growth factor receptor 3 in mouse downregulates Ihh/PTHrP signals and causes severe achondroplasia.
    Chen L; Li C; Qiao W; Xu X; Deng C
    Hum Mol Genet; 2001 Mar; 10(5):457-65. PubMed ID: 11181569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gly380Arg and Asn540Lys mutations of fibroblast growth factor receptor 3 in achondroplasia and hypochndroplasia in the Spanish population].
    Ezquieta Zubicaray B; Iguacel AO; Varela Junquera JM; Jariego Fente CM; González Gancedo P; Gracia Bouthelier R
    Med Clin (Barc); 1999 Mar; 112(8):290-3. PubMed ID: 10207844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achondroplasia: pathogenesis and implications for future treatment.
    Laederich MB; Horton WA
    Curr Opin Pediatr; 2010 Aug; 22(4):516-23. PubMed ID: 20601886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Achondroplasia in Turkey is defined by recurrent G380R mutation of the FGFR3 gene.
    Pehlivan S; Ozkinay F; Okutman O; Coğulu O; Ozcan A; Cankaya T; Ulgenalp A
    Turk J Pediatr; 2003; 45(2):99-101. PubMed ID: 12921294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia.
    Webster MK; Donoghue DJ
    EMBO J; 1996 Feb; 15(3):520-7. PubMed ID: 8599935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype.
    Murakami S; Balmes G; McKinney S; Zhang Z; Givol D; de Crombrugghe B
    Genes Dev; 2004 Feb; 18(3):290-305. PubMed ID: 14871928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Achondroplasia: molecular study of 28 patients].
    Climent C; Lorda-Sánchez I; Urioste M; Gairi JM; Rodríguez JI; Rubio V
    Med Clin (Barc); 1998 Apr; 110(13):492-4. PubMed ID: 9611730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Updated treatment of achondroplasia].
    Seino Y
    Clin Calcium; 2009 Mar; 19(3):432-6. PubMed ID: 19252254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predominance of the mutation at 1138 of the cDNA for the fibroblast growth factor receptor 3 in Japanese patients with achondroplasia.
    Tonoki H; Nakae J; Tajima T; Shinohara N; Monji J; Satoh S; Fujieda K
    Jpn J Hum Genet; 1995 Dec; 40(4):347-9. PubMed ID: 8851771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotyping of the G1138A mutation of the FGFR3 gene in patients with achondroplasia using high-resolution melting analysis.
    Hung CC; Lee CN; Chang CH; Jong YJ; Chen CP; Hsieh WS; Su YN; Lin WL
    Clin Biochem; 2008 Feb; 41(3):162-6. PubMed ID: 18199430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mutation analysis of fibroblast growth factor receptor 3 gene in an achondroplasia family].
    Zhu B; Dong QM; Huang XH; Ji GQ; Chen Y; Wang WX; Jiang HY; Gao JS
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Oct; 20(5):373-5. PubMed ID: 14556186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia.
    Rousseau F; Bonaventure J; Legeai-Mallet L; Pelet A; Rozet JM; Maroteaux P; Le Merrer M; Munnich A
    Nature; 1994 Sep; 371(6494):252-4. PubMed ID: 8078586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of FGFR3 with the G380R achondroplasia mutation inhibits proliferation and maturation of CFK2 chondrocytic cells.
    Henderson JE; Naski MC; Aarts MM; Wang D; Cheng L; Goltzman D; Ornitz DM
    J Bone Miner Res; 2000 Jan; 15(1):155-65. PubMed ID: 10646125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An improved methodology for the detection of the common mutation in the FGFR3 gene responsible for achondroplasia.
    Lanning RW; Brown CA
    Hum Mutat; 1997; 10(6):496-9. PubMed ID: 9401015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.